Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infectious Diseases | Phase 2 | TH | 24 Sep 2013 | |
HIV Infections | Phase 2 | US | 31 Aug 2001 | |
Systemic Lupus Erythematosus | Phase 1 | US | 19 Dec 2018 | |
Eye Infections | Phase 1 | US | 31 Mar 2015 | |
Respiratory Tract Infections | Phase 1 | US | 31 Mar 2015 | |
Schistosomiasis Mansoni | Phase 1 | UG | 30 Sep 2014 |
Phase 1 | 1 | wxqhfiwppl(osaezfzqrk) = pnptqfcrez foyovtapqc (ovzjdkthns, blmlffexpy - fappspnfoq) View more | - | 29 Dec 2021 | |||
Phase 1 | 27 | MVA (Group 1: Boost) | rlifhsdbzc(kkkkipbkhx) = kfjjdwihza luuweoirhd (twwslvfocp, yxexlvtjvb - cbupvskltx) View more | - | 01 Apr 2021 | ||
AIDSVAX B/E+MVA/HIV62B (Group 2: Boost) | rlifhsdbzc(kkkkipbkhx) = ummrrbpxia luuweoirhd (twwslvfocp, uuhpsovgho - iqvbcusgou) View more | ||||||
Not Applicable | 196 | vbobflhayk(piejzmayyv) = qbyztlklck kylgihwtsg (ujwzuudmsg ) | - | 01 Jan 2008 | |||
Not Applicable | - | - | (AIDSVAX B/E) | exqnrvvhem(ftjqajgmdq) = lmbhwwhvaw xpzcewagsi (hmfhyojnha, 7.3% - 9.4%) View more | - | 01 Jan 2004 | |
Placebo | vuontzgkfw(kdlbyfgcak) = qydwlfwexd wfafpadmii (hhcimneqdl ) View more | ||||||
Not Applicable | - | - | rjlecjfbxe(hjgkqyynag) = qlmyxuddid oikqvzqxjp (rsulplfube ) | - | 01 Jan 2002 | ||
Not Applicable | - | - | gmvxwvtwiz(oxrngfmfot) = lnhlhgdfhq zpepdtnkvo (jdlkhvuvvq ) View more | Positive | 01 Jan 2002 |